Mission: Cure


blood samplesMission: Cure is using outcome-based financing and impact investing to demonstrate a new model for curing disease.

The first disease Mission: Cure is attacking is chronic pancreatitis. The world’s top pancreatic experts believe a well-funded, coordinated research and development program could lead to effective treatments within 10 years. In partnership with the National Pancreas Foundation, Mission: Cure is working to make that happen. Consulting with pancreatic experts from the nation’s top research and healthcare institutions, it is developing a 10-year plan.

Mission: Cure will get commitments from impact philanthropists and from those who bear the costs of chronic pancreatitis to pay for significant improvements in patient outcomes over a defined timeframe. These incentives for patient outcomes will complement existing market incentives for development of therapies for orphan diseases. Impact investors will then invest in a portfolio of strategies designed to achieve the agreed-upon patient outcomes.

Repurposing of existing drugs, devices and nutraceuticals will be a central strategy to quickly and affordably improve patients’ lives. Mission: Cure will convene and support a coalition of interested parties, including investors, government and private outcome payers, patients and the experts researching and treating people regularly, to problem-solve and project-manage to achieve the outcomes on schedule. If successful, the impact investors will not only help measurably improve people’s lives but will also earn a financial return on their investment.

Meet Megan Golden, co-founder of Mission: Cure

Contact Megan

Official Website of Mission: Cure





Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*


If the link above doesn't work, please contact our Admin support at admin@cureswithinreach.org with your Full Name and Email Address to sign up!


Cures Within Reach

134 N. LaSalle, #1130
Chicago, IL 60602


All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.


Sunday the 15th. Copyright 2018 Cures Within Reach.